Diamond Ranch Foods (PLPL) 0.0145 $PLPL Plandai
Post# of 273333
Posted On: 09/24/2016 5:06:34 AM
Diamond Ranch Foods (PLPL) 0.0145 $PLPL
Plandai Biotechnology Announces Agreement in Principal for New Clinical Trials to Evaluate Effectiveness of Phytofare in Treating Type II Diabetes
Marketwired - Thu Aug 25, 6:00AM CDT
Planned Mauritius-Based Study to Be Undertaken by North West University South Africa to Determine Impact of Highly Bioavailable Catechins on Blood Sugar Regulation
Plandai Biotechnology to Host Investor Update Conference Call on Friday June 3, 2016 11a.m. ET
Marketwired - Wed Jun 01, 12:29PM CDT
LONDON, UNITED KINGDOM--(Marketwired - Jun 1, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"
, producer of the highly bioavailable Phytofare® catechin complex, today announced it will be hosting an investor update conference call for Friday, June 3, at 11a.m. Eastern Time. The call will feature Board of Directors member and vice president of sales and marketing, Mr. Callum Cottrell-Duffield. The conference call dial-in information is:
Plandai Biotechnology, Inc. Announces New Process That Could Pave the Way to Using Phytofare for Domestic Animals Including Livestock and Pets
Marketwire Canada - Tue May 24, 6:01AM CDT
Revised Trial Expected to Commence June 2016
Plandai Biotechnology, Inc. Announces Vitamin Express to Release New Product Containing Phytofare(R)
Marketwired - Tue May 10, 6:00AM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 10, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company" , producer of the highly bioavailable Phytofare® catechin complex, today announced VitaminExpress, a highly successful health supplement company based in the European Union, is set to release a new product this month, with Phytofare® Catechin Complex as the main ingredient, which will be incorporated into their current product line. Vitamin Express has shipped an astounding 5 million products over the previous 20 years, with customers throughout Western and Eastern Europe.
Plandai Biotechnology, Inc. Announces Record Sales Volume for April
Marketwired - Fri Apr 29, 6:00AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company" , producer of the highly bioavailable Phytofare(R) catechin complex, today announced that April 2016 saw the company sell and ship 425 kilograms of product, representing approximately $60,000 in revenues. In addition, since January, Plandai announced that customers have released to market a total of ten new branded consumer products that contain Phytofare(R), which are being sold in Australia, Western Europe and Africa. Products containing Phytofare(R) should be on shelves in United States as early as May.
Plandai Biotechnology reports sale of Phytofare in three continents
M2 - Tue Jan 26, 3:06AM CST
Phyto-available extract company Plandai Biotechnology (OTCQB
LPL) reported on Monday that Phytofare is being marketed and sold in Africa, Europe and Australia.
Plandai Biotechnology, Inc. Announces Phytofare Sales on Three Continents
Marketwired - Mon Jan 25, 8:01AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company" , producer of the highly bioavailable Phytofare(R) catechin complex, today announced that the Company is actively selling Phytofare(R) in Africa, Europe and Australia, where various customers use Phytofare(R) as the active ingredient in their formulated products. Sales of Phytofare(R) to United States customers are considered imminent, with sales to China anticipated later in the year.
Plandai Biotechnology, Inc. Announces Phytofare(R) Used as Key Ingredient in New Fat Burner Product
Marketwired - Wed Jan 13, 10:08AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company" , producer of the highly bioavailable Phytofare(R) catechin complex, today announced that TNT Supplements recently launched their new product, TNT Fat Burner, in the United Kingdom. TNT contains a unique blend of ingredients that have never before been used in tandem, one of which is Plandai's Phytofare(R) catechin complex. Phytofare(R) is a highly bioavailable green tea-based extract that is unique in having clinical data demonstrating ten times greater bioavailability over generic green tea extracts. Furthermore, Phytofare(R) consists of all eight catechins found in green tea, not just ECGC which is found in most weight loss products.
Plandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016
Marketwired - Mon Dec 28, 8:00AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company" , a producer of highly bioavailable Phytofare(R) Catechin Complex, today reviewed the results and current standings for 2015 and discussed plans for the future as they look to 2016.
Plandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock
Marketwired - Wed Nov 18, 8:01AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company" , producer of the highly bioavailable Phytofare(R) catechin complex, today announced that its wholly-owned subsidiary, Red Gold (Pty) Ltd., has reached an agreement with Deltamune (Pty) Ltd., a South African-based veterinary research and testing company that also develops and manufactures vaccines for treating Avian Influenza, Infectious Coryza, Egg Drop syndrome and Newcastle disease. Under the terms of the agreement, Deltamune will undertake clinical trials using Plandai's Phytofare(R) Catechin Complex and Citrus Complex to determine the efficacy of the combined all-natural products in helping prevent diseases in poultry. Should the trials prove successful, the parties will move towards executing a production license and distribution agreement.
Plandai Biotechnology signs Phytofare distribution agreement with Bal Pharma Ltd for India
M2 - Wed Oct 28, 5:14AM CDT
Plandai Biotechnology (OTCQB LPL) reported on Tuesday the launch of an exclusive Phytofare distribution Agreement with Bal Pharma, an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients.
Plandai Biotechnology, Inc. Announces Distribution Agreement With Bal Pharma Ltd Covering India
Marketwired - Tue Oct 27, 8:33AM CDT
Plandai Biotechnology, Inc. ("Plandai" or "the Company" (OTCQB: PLPL), producer of the highly bioavailable Phytofare(R), today announced that it has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients (www.balpharma.com). Under the terms of the agreement, Bal Pharma will use the Company's Phytofare(R) in their finished formulation products while also distributing Phytofare(R) as an active ingredient throughout India. The two-year renewable agreement gives Bal Pharma exclusivity for their territory and fixed pricing based on volume in exchange for defined annual off take.
Plandai Biotechnology, Inc. Announces Distribution Agreement with Coyne Healthcare for Phytofare(R)/Pheriod Finished Product(R)
ACCESSWIRE - Mon Oct 12, 8:54AM CDT
Shipments of Ph(2)(TM) Expected to Commence November 2015
North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.16 (-0.01), INSY: 12.56 (-0.32), ARNA: 1.74 (-0.03)
Multi-Billion Dollar Legal Cannabis Market Gaining Ground State By State As Companies Focus on Introducing Groundbreaking Products & Services with New Leadership
PR Newswire - Tue Sep 01, 7:30AM CDT
Cannabis, Hemp & Legal Marijuana business appears to be one of the fastest-growing sector in the U.S. and if the growth and expansion toward legalization spreads to all 50 states, the sector could become larger than the organic food industry, according to a new report obtained by The Huffington Post. Active companies in the industry with recent developments of importance are Surna Inc. (OTC: SRNA), Cherubim Interests Inc. (OTC: CHIT), Plandaí Biotechnology, Inc. (OTC: PLPL), Medical Marijuana, Inc.'s (OTC: MJNA), Hemp, Inc. (OTC: HEMP) and Pazoo, Inc. (OTC: PZOO).
Plandai Biotechnology, Inc. Announces Expansion of Agreement With USN to Now Include the European Union
Marketwired - Mon Aug 10, 8:01AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , producer of the highly bioavailable Phytofare® catechin complex, today announced an amendment to its previously announced agreement with USN Worldwide. By virtue of the amended agreement with USN, the Company will now expand its exclusive Phytofare® sales to USN and its contract manufacturers to the European Union.
Plandai Biotechnology Announces Agreement in Principal for New Clinical Trials to Evaluate Effectiveness of Phytofare in Treating Type II Diabetes
Marketwired - Thu Aug 25, 6:00AM CDT
Planned Mauritius-Based Study to Be Undertaken by North West University South Africa to Determine Impact of Highly Bioavailable Catechins on Blood Sugar Regulation
Plandai Biotechnology to Host Investor Update Conference Call on Friday June 3, 2016 11a.m. ET
Marketwired - Wed Jun 01, 12:29PM CDT
LONDON, UNITED KINGDOM--(Marketwired - Jun 1, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"
, producer of the highly bioavailable Phytofare® catechin complex, today announced it will be hosting an investor update conference call for Friday, June 3, at 11a.m. Eastern Time. The call will feature Board of Directors member and vice president of sales and marketing, Mr. Callum Cottrell-Duffield. The conference call dial-in information is: Plandai Biotechnology, Inc. Announces New Process That Could Pave the Way to Using Phytofare for Domestic Animals Including Livestock and Pets
Marketwire Canada - Tue May 24, 6:01AM CDT
Revised Trial Expected to Commence June 2016
Plandai Biotechnology, Inc. Announces Vitamin Express to Release New Product Containing Phytofare(R)
Marketwired - Tue May 10, 6:00AM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 10, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"
, producer of the highly bioavailable Phytofare® catechin complex, today announced VitaminExpress, a highly successful health supplement company based in the European Union, is set to release a new product this month, with Phytofare® Catechin Complex as the main ingredient, which will be incorporated into their current product line. Vitamin Express has shipped an astounding 5 million products over the previous 20 years, with customers throughout Western and Eastern Europe. Plandai Biotechnology, Inc. Announces Record Sales Volume for April
Marketwired - Fri Apr 29, 6:00AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company"
, producer of the highly bioavailable Phytofare(R) catechin complex, today announced that April 2016 saw the company sell and ship 425 kilograms of product, representing approximately $60,000 in revenues. In addition, since January, Plandai announced that customers have released to market a total of ten new branded consumer products that contain Phytofare(R), which are being sold in Australia, Western Europe and Africa. Products containing Phytofare(R) should be on shelves in United States as early as May. Plandai Biotechnology reports sale of Phytofare in three continents
M2 - Tue Jan 26, 3:06AM CST
Phyto-available extract company Plandai Biotechnology (OTCQB
LPL) reported on Monday that Phytofare is being marketed and sold in Africa, Europe and Australia. Plandai Biotechnology, Inc. Announces Phytofare Sales on Three Continents
Marketwired - Mon Jan 25, 8:01AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company"
, producer of the highly bioavailable Phytofare(R) catechin complex, today announced that the Company is actively selling Phytofare(R) in Africa, Europe and Australia, where various customers use Phytofare(R) as the active ingredient in their formulated products. Sales of Phytofare(R) to United States customers are considered imminent, with sales to China anticipated later in the year. Plandai Biotechnology, Inc. Announces Phytofare(R) Used as Key Ingredient in New Fat Burner Product
Marketwired - Wed Jan 13, 10:08AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company"
, producer of the highly bioavailable Phytofare(R) catechin complex, today announced that TNT Supplements recently launched their new product, TNT Fat Burner, in the United Kingdom. TNT contains a unique blend of ingredients that have never before been used in tandem, one of which is Plandai's Phytofare(R) catechin complex. Phytofare(R) is a highly bioavailable green tea-based extract that is unique in having clinical data demonstrating ten times greater bioavailability over generic green tea extracts. Furthermore, Phytofare(R) consists of all eight catechins found in green tea, not just ECGC which is found in most weight loss products. Plandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016
Marketwired - Mon Dec 28, 8:00AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company"
, a producer of highly bioavailable Phytofare(R) Catechin Complex, today reviewed the results and current standings for 2015 and discussed plans for the future as they look to 2016. Plandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock
Marketwired - Wed Nov 18, 8:01AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL) ("Plandai" or "the Company"
, producer of the highly bioavailable Phytofare(R) catechin complex, today announced that its wholly-owned subsidiary, Red Gold (Pty) Ltd., has reached an agreement with Deltamune (Pty) Ltd., a South African-based veterinary research and testing company that also develops and manufactures vaccines for treating Avian Influenza, Infectious Coryza, Egg Drop syndrome and Newcastle disease. Under the terms of the agreement, Deltamune will undertake clinical trials using Plandai's Phytofare(R) Catechin Complex and Citrus Complex to determine the efficacy of the combined all-natural products in helping prevent diseases in poultry. Should the trials prove successful, the parties will move towards executing a production license and distribution agreement. Plandai Biotechnology signs Phytofare distribution agreement with Bal Pharma Ltd for India
M2 - Wed Oct 28, 5:14AM CDT
Plandai Biotechnology (OTCQB
LPL) reported on Tuesday the launch of an exclusive Phytofare distribution Agreement with Bal Pharma, an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients. Plandai Biotechnology, Inc. Announces Distribution Agreement With Bal Pharma Ltd Covering India
Marketwired - Tue Oct 27, 8:33AM CDT
Plandai Biotechnology, Inc. ("Plandai" or "the Company"
(OTCQB: PLPL), producer of the highly bioavailable Phytofare(R), today announced that it has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients (www.balpharma.com). Under the terms of the agreement, Bal Pharma will use the Company's Phytofare(R) in their finished formulation products while also distributing Phytofare(R) as an active ingredient throughout India. The two-year renewable agreement gives Bal Pharma exclusivity for their territory and fixed pricing based on volume in exchange for defined annual off take. Plandai Biotechnology, Inc. Announces Distribution Agreement with Coyne Healthcare for Phytofare(R)/Pheriod Finished Product(R)
ACCESSWIRE - Mon Oct 12, 8:54AM CDT
Shipments of Ph(2)(TM) Expected to Commence November 2015
North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.16 (-0.01), INSY: 12.56 (-0.32), ARNA: 1.74 (-0.03)
Multi-Billion Dollar Legal Cannabis Market Gaining Ground State By State As Companies Focus on Introducing Groundbreaking Products & Services with New Leadership
PR Newswire - Tue Sep 01, 7:30AM CDT
Cannabis, Hemp & Legal Marijuana business appears to be one of the fastest-growing sector in the U.S. and if the growth and expansion toward legalization spreads to all 50 states, the sector could become larger than the organic food industry, according to a new report obtained by The Huffington Post. Active companies in the industry with recent developments of importance are Surna Inc. (OTC: SRNA), Cherubim Interests Inc. (OTC: CHIT), Plandaí Biotechnology, Inc. (OTC: PLPL), Medical Marijuana, Inc.'s (OTC: MJNA), Hemp, Inc. (OTC: HEMP) and Pazoo, Inc. (OTC: PZOO).
Plandai Biotechnology, Inc. Announces Expansion of Agreement With USN to Now Include the European Union
Marketwired - Mon Aug 10, 8:01AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, producer of the highly bioavailable Phytofare® catechin complex, today announced an amendment to its previously announced agreement with USN Worldwide. By virtue of the amended agreement with USN, the Company will now expand its exclusive Phytofare® sales to USN and its contract manufacturers to the European Union. 
(0)
(0)